We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Commentary: Access to Psychedelics for Psychological Suffering at the End of Life -- Prioritizing Our Priorities.
- Authors
ROSENBAUM, DANIEL; HALES, SARAH; BUCHMAN, DANIEL Z.
- Abstract
We agree with Kratina et al. (2023) that the problem of psychological suffering at the end of life deserves attention from a policy standpoint and that psychedelic therapies show promise in this clinical context. However, we argue the following in this rejoinder: (1) disproportionate attention to psychedelics may overstate the current evidence base, potentially diverting resources away from existing evidence-based programs; (2) a more pressing policy priority related to this public health problem is to address population-level inequities in accessing high-quality, early and holistic palliative care, including psychosocial care; and (3) discussions about expanded access to psychedelics must also foreground equity issues.
- Subjects
HEALTH policy; HEALTH services accessibility; CATASTROPHIC illness; HEALTH equity; PSYCHOLOGICAL stress; HALLUCINOGENIC drugs
- Publication
Healthcare Policy, 2023, Vol 18, Issue 4, p143
- ISSN
1715-6572
- Publication type
Article
- DOI
10.12927/hcpol.2023.27047